文献速递生殖医学

人胚胎胞质丝与活产结局改善相关:系统综述与荟萃分析

Cytoplasmic strings in human in-vitro embryos are a promising indicator for enhanced live-birth outcomes: a systematic review and meta-analysis.
PubMed 文献 · Hum Reprod Update · 2026-08-26

该研究系统综述并荟萃分析了人囊胚胞质丝(CS)对IVF结局的影响,纳入13项研究12个数据集共7583枚囊胚。CS+囊胚活产率(OR=1.88,95%CI:1.35-2.61)、临床妊娠率(OR=2.20,95%CI:1.29-3.75)及优质形态率(OR=2.40,95%CI:1.17-4.92)均显著高于CS-囊胚,但GRADE证据确定性极低。

要点

  • CS+囊胚活产率、临床妊娠率和优质形态率均显著高于CS-囊胚。
  • CS数量≥5枚、出现早及消失早均与更好的发育潜能相关。
  • GRADE证据确定性极低,需更多研究验证CS的生物学作用。

核心结论

  • 人囊胚胞质丝与IVF活产率及临床妊娠率改善相关。
  • CS数量增加、出现早和消失早均与更好的胚胎发育潜能相关。
  • GRADE评估因高异质性和偏倚,证据确定性极低。

研究设计与样本

  • 系统综述与荟萃分析,遵循PRISMA指南,检索PubMed、Embase、Medline、Cochrane Library和Web of Science(1946年至2025年9月30日)。
  • 纳入24篇文章,其中15项观察性研究含14个数据集。
  • 荟萃分析纳入13项研究12个数据集,共7583枚囊胚(CS+ 4417枚,CS- 3166枚)。
  • 使用随机效应模型计算OR、SMD和MD,采用ROBINS-E和漏斗图评估偏倚。

主要发现

  • CS+囊胚活产率更高(OR=1.88,95%CI:1.35-2.61,I²=55%,n=2766枚移植囊胚,6项研究)。
  • CS+囊胚临床妊娠率更高(OR=2.20,95%CI:1.29-3.75,I²=59%,n=1963,5项研究)。
  • CS+囊胚优质形态几率更高(OR=2.40,95%CI:1.17-4.92,I²=82%,n=1967,5项研究)。
  • CS≥5枚 vs 1-4枚的活产率OR=3.01(95%CI:2.22-4.08,I²=0%,n=1300,3项研究)。
  • CS+囊胚各形态动力学阶段进展更快,尤其囊胚形成后(全囊胚时间SMD=-0.75,95%CI:-0.99至-0.52,I²=53%,n=1525,3项研究)。

关键数值与推荐

  • CS+囊胚活产率OR=1.88(95%CI:1.35-2.61),临床妊娠率OR=2.20(95%CI:1.29-3.75)。
  • CS+囊胚优质形态率OR=2.40(95%CI:1.17-4.92)。
  • CS数量≥5枚 vs 1-4枚的OR=3.01(95%CI:2.22-4.08)。
  • CS出现时间SMD=-0.44(95%CI:-0.58至-0.30),消失时间SMD=-0.45(95%CI:-0.59至-0.30)。

临床怎么用

  • 将CS评估整合入囊胚评价方案可能改善胚胎选择策略。
  • CS可作为胚胎挑选的附加形态学指标,但需结合其他指标综合判断。
  • 鉴于证据确定性极低,CS评估不应单独用于临床决策。

局限性

  • GRADE评估证据确定性极低,因高异质性和偏倚风险。
  • 纳入研究多为观察性研究,可能存在混杂因素。
  • CS的生物学作用及其对胚胎活力的影响尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Cytoplasmic strings (CS) are transient filamentous connections which traverse the blastocoel, connecting the inner cell mass to the mural trophectoderm in blastocysts. Although they have been observed in animal studies for years, their role in embryogenesis remains unclear. At first, CS were considered abnormal in expanded blastocysts, but recent time-lapse studies on human in-vitro embryos suggest that CS may indicate higher developmental potential. Although CS are now included in morphological and morphokinetic guidelines, their impact on embryo viability remains inconclusive due to limited evidence. OBJECTIVE AND RATIONALE: The aim of this review was to investigate whether CS in human in-vitro blastocysts influences IVF and pregnancy outcomes, primarily as indicated by livebirth rates. SEARCH METHODS: This systematic review and meta-analysis followed PRISMA guidelines. PubMed, Embase, Medline, Cochrane Library, and Web of Science were searched using key terms 'cytoplasmic strings' and related MeSH terms from 1946 till 30 September 2025 for all languages. Studies were selected per the PICO framework, screened independently, and back-reference searched. Inclusion criteria were studies on preimplantation embryos with CS. Meta-analysis required studies with control blastocysts without CS, and reporting on either the primary outcome, livebirth rate (LBR), or secondary outcomes, clinical pregnancy rate (CPR), embryo quality, morphokinetics, CS characteristics, and patient treatment characteristics. Non-human studies were excluded. Data were extracted for meta-analysis and represented in odds ratios (OR), standardized mean differences (SMD), and mean differences utilizing random-effects models on Revman v5.4. Bias was assessed via ROBINS-E and funnel plots, with subgroup analyses performed based on variables identified. OUTCOMES: From 1029 publications screened, 24 articles, including 15 observational studies with 14 datasets, were included. Meta-analysis of 13 studies (12 datasets) included 7583 blastocysts analysed for CS presence: 4417 exhibited CS (CS+), while 3166 did not (CS-). CS + blastocysts were associated with a higher LBR (OR = 1.88, 95% CI: 1.35, 2.61, I² = 55%, n = 2766 transferred blastocysts, 6 studies) and an increase in CPR (OR = 2.20, 95% CI: 1.29-3.75, I² = 59%, n = 1963, 5 studies). CS + blastocysts also demonstrated higher odds of good morphological quality (OR = 2.40, 95% CI: 1.17-4.92, I2 = 82%, n = 1967, 5 studies). Furthermore, this relationship was maintained with increased quantities of CS (blastocysts with ≥5 CS vs 1-4 CS: OR = 3.01, 95% CI: 2.22, 4.08, I2 = 0%, n = 1300, 3 studies), earlier CS onset, measured by hours post insemination (hpi), (SMD = -0.44, 95% CI: -0.58, -0.30, I2 = 9%, n = 972 blastocysts, 3 studies) and earlier disappearance of CS (SMD = -0.45, 95% CI: -0.59, -0.30, I2 = 13%, n = 962 blastocysts, 3 studies). Additionally, CS + blastocysts reached each successive morphokinetic stage progressively faster compared to CS - blastocysts, particularly post-blastulation (time of full blastocyst: SMD = -0.75, 95% CI: -0.99, -0.52, I2 = 53% n = 1525, 3 studies). GRADE assessment indicated very low certainty secondary to high heterogeneity and bias. WIDER IMPLICATIONS: Our meta-analysis demonstrated that CS in human in-vitro blastocysts is associated with improved IVF outcomes. Further research on the biological role of CS in embryogenesis and their influence on embryo viability is necessary. Following these answers, the integration of CS assessment into blastocyst evaluation protocols could improve embryo selection strategies and ultimately improve pregnancy success rates in IVF. REGISTRATION NUMBER: PROSPERO (CRD420250652014).

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Dodhia VF, Ng KYB, Fleming TP, et al. Cytoplasmic strings in human in-vitro embryos are a promising indicator for enhanced live-birth outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2026. PMID: 42647895. doi:10.1093/humupd/dmag026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。